Intelligent Surfaces Inc. In modern healthcare, numerous implantable medical devices, such as artificial blood vessels, are used, but they often trigger biological reactions such as protein adsorption and thrombus formation due to being recognized as foreign substances by the body. Intelligent Surfaces has developed the revolutionary MPC polymer utilizing cutting-edge biomimetic technology, which contains components similar to phospholipids found in human biomembranes.

By coating implantable medical devices with the MPC polymer, the devices' surfaces are recognized by the body as biomembranes, allowing for the development of medical devices with reduced biological reactions. Intelligent Surfaces aims to transform artificial material surfaces into natural and functional surfaces to achieve functional fusion between humans and machines, life and machines, and nature and machines. Led by founder and CEO Dr.

Yoshihiro Kiritoshi, the company continues to strive towards realizing their vision using this innovative material originally invented and developed at Tokyo Medical and Dental University and Tokyo University